DI BARTOLOMEO, E.; SANTARONE, S.; BAVARO, P.; DI CARLO, P.; OLIOSO, P.; PAPALINETTI, G.; DI BARTOLOMEO, P. Once-daily intravenous busulfan as myeloablative, reduced-toxicity conditioning regimen: results in young and adult patients with hematological malignant and nonmalignant diseases. Hematology Meeting Reports (formerly Haematologica Reports), [S. l.], v. 2, n. 6, 2009. DOI: 10.4081/hmr.v2i6.771. Disponível em: https://www.pagepress.org/journals/hmr/article/view/771. Acesso em: 21 nov. 2024.